Evidence map›Paper›PMID 42603059›Full record

ArticleEuropean heart journal. Case reports2026

Dual percutaneous management of Dunning type III iatrogenic aortic dissection during percutaneous coronary intervention: a case report.

Lin Chen, Fandy Santoso Budiardjo, Xiaofang Chen, Huiyuan Kang, Ye Cheng

Abstract readCase Reports
In one paragraph

Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lin ChenDepartment of Cardiology, The Xiamen Cardiovascular Hospital of Xiamen University, No. 2999 Jinshan Road, Huli District, Xiamen, Fujian 361000, China.
Fandy Santoso BudiardjoDepartment of Cardiology, The Xiamen Cardiovascular Hospital of Xiamen University, No. 2999 Jinshan Road, Huli District, Xiamen, Fujian 361000, China.ORCID https://orcid.org/0009-0004-1556-4607
Xiaofang ChenDepartment of Cardiology, The Xiamen Cardiovascular Hospital of Xiamen University, No. 2999 Jinshan Road, Huli District, Xiamen, Fujian 361000, China.ORCID https://orcid.org/0009-0009-7948-8750
Huiyuan KangDepartment of Cardiology, The Xiamen Cardiovascular Hospital of Xiamen University, No. 2999 Jinshan Road, Huli District, Xiamen, Fujian 361000, China.ORCID https://orcid.org/0009-0002-4077-9509
Ye ChengDepartment of Cardiology, The Xiamen Cardiovascular Hospital of Xiamen University, No. 2999 Jinshan Road, Huli District, Xiamen, Fujian 361000, China.ORCID https://orcid.org/0000-0003-2340-7228

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Iatrogenic aortocoronary dissection (IACD) is an uncommon but potentially life-threatening complication of percutaneous coronary intervention (PCI). Case summary: We report the case of a 64-year-old male who developed IACD (Dunning type II) during PCI of right coronary artery. Initial bailout with drug-eluting stents (DSE) implantation but failed to completely exclude a retrograde tear into the aortic root. A larger covered stent (CS) was successfully deployed at the ostium halting the progression of the aortic dissection. Conclusion: This case highlights that for PCI-induced IACD refractory to conventional DES, a CS provides a definitive barrier to halt dissection. A prompt percutaneous bailout, reinforced by strict haemodynamic control and surgical standby, is crucial for managing this catastrophic complication.

Indexed as

Aortocoronary dissectionCase reportCovered stentDrug-eluting stentDunning classificationPercutaneous treatment

Identifiers

PMID42603059
PMCPMC13475803

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.